Literature DB >> 9627653

Multiple cases of acquired toxoplasmosis retinitis presenting in an outbreak.

A J Burnett1, S G Shortt, J Isaac-Renton, A King, D Werker, W R Bowie.   

Abstract

OBJECTIVE: The purpose of the study was to examine the variability in presentation and outcome of individuals presenting with acquired toxoplasmosis retinitis in the setting of an outbreak of the disease.
DESIGN: The study design was a case series. PARTICIPANTS: Twenty-one eyes of 20 patients with equal gender distribution and a mean age of 54 years followed for 38 to 170 weeks (mean 113.7 weeks) were studied. INTERVENTION: Systemic antimicrobials and corticosteroids when indicated were given. MAIN OUTCOME MEASURES: Visual acuity, media inflammation and clarity, resolution of active retinitis, and appearance of recurrence were observed.
RESULTS: Fifteen of 21 lesions were active, and 7 of the total number of lesions fell within the macula-peripapillary region. Overall, vision improved with treatment except in cases of macular involvement (3 cases) and persistent vitritis (3 cases). Four recurrences have occurred to date.
CONCLUSIONS: This is the largest reported outbreak of acquired toxoplasmosis retinitis occurring within a single outbreak. Twenty-one eyes of 20 patients presented with retinal lesions, and on average, those treated for active retinitis had improvement in vision.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9627653     DOI: 10.1016/S0161-6420(98)96004-3

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  45 in total

1.  Is ocular toxoplasmosis caused by prenatal or postnatal infection?

Authors:  R E Gilbert; M R Stanford
Journal:  Br J Ophthalmol       Date:  2000-02       Impact factor: 4.638

2.  Acquired ocular toxoplasmosis in pregnancy.

Authors:  M Ramchandani; J B Weaver; D H M Joynson; P I Murray
Journal:  Br J Ophthalmol       Date:  2002-08       Impact factor: 4.638

3.  CXCL10 is required to maintain T-cell populations and to control parasite replication during chronic ocular toxoplasmosis.

Authors:  Kazumi Norose; Akitoshi Kikumura; Andrew D Luster; Christopher A Hunter; Tajie H Harris
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-01-21       Impact factor: 4.799

4.  Determining UV inactivation of Toxoplasma gondii oocysts by using cell culture and a mouse bioassay.

Authors:  Michael W Ware; Swinburne A J Augustine; David O Erisman; Mary Jean See; Larry Wymer; Samuel L Hayes; J P Dubey; Eric N Villegas
Journal:  Appl Environ Microbiol       Date:  2010-06-11       Impact factor: 4.792

5.  Multiplex PCR for typing strains of Toxoplasma gondii.

Authors:  Daniel Ajzenberg; Aurélien Dumètre; Marie-Laure Dardé
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

Review 6.  Toxoplasmosis: A history of clinical observations.

Authors:  Louis M Weiss; Jitender P Dubey
Journal:  Int J Parasitol       Date:  2009-02-13       Impact factor: 3.981

Review 7.  Sexual recombination punctuated by outbreaks and clonal expansions predicts Toxoplasma gondii population genetics.

Authors:  Michael E Grigg; Natarajan Sundar
Journal:  Int J Parasitol       Date:  2009-02-13       Impact factor: 3.981

8.  Toxoplasmic retinochoroiditis presenting in childhood: clinical findings in a UK survey.

Authors:  M R Stanford; H K Tan; R E Gilbert
Journal:  Br J Ophthalmol       Date:  2006-08-09       Impact factor: 4.638

9.  Inflammatory choroidal neovascularization.

Authors:  Piergiorgi Neri; Marta Lettieri; Cinzia Fortuna; Mara Manoni; Alfonso Giovannini
Journal:  Middle East Afr J Ophthalmol       Date:  2009-10

10.  Toxoplasmosis and Toxocariasis: An Assessment of Human Immunodeficiency Virus Comorbidity and Health-Care Costs in Canada.

Authors:  Janna M Schurer; Ellen Rafferty; Michael Schwandt; Wu Zeng; Marwa Farag; Emily J Jenkins
Journal:  Am J Trop Med Hyg       Date:  2016-05-02       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.